Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
947 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
21 Completed Pharmacogenetic Testing Among Home Health Patients
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention: Genetic: Pharmacogenetic testing
22 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
23 Recruiting Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
Condition: Atrial Fibrillation
Interventions: Genetic: Pharmacogenetic anticoagulation;   Drug: Traditional anticoagulation
24 Recruiting The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.
Conditions: Heart Valve Disease;   Older Than 18-years-old;   Without Any Liver or Kidney Diseases
Intervention: Genetic: CYP2C9;VKORC1
25 Completed
Has Results
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
Condition: Thromboembolism
Interventions: Genetic: IWPC adapted genotype-guided dosing algorithm for warfarin;   Genetic: Modified IWPC genetic-guided warfarin dosing algorithm;   Other: Standard of care treatment
26 Completed Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions
Condition: Healthcare
Intervention: Other: DDI+ System and Pharmacogenetic Data
27 Completed Pharmacogenetic Testing in Primary Care
Condition: Pharmacogenetic Testing
Intervention:
28 Completed Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
29 Not yet recruiting A Research in Pharmacogenomics and Accurate Medication of New Antiplatelet Drug Ticagrelor
Conditions: Ticagrelor;   Pharmacokinetics;   Pharmacodynamics;   Pharmacogenomics;   Accurate Medication
Intervention: Genetic: detection of genotype
30 Recruiting Pharmacogenomics of New Antiretrovirals
Condition: HIV
Intervention:
31 Completed
Has Results
Clopidogrel Pharmacogenomics Project
Condition: Disease Susceptibility
Interventions: Drug: clopidogrel 75 mg;   Drug: Clopidogrel 150 mg
32 Withdrawn Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Cetuximab
33 Completed
Has Results
Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting
Condition: Depression
Intervention: Other: Pharmacogenomic algorithm
34 Enrolling by invitation Integrating Pharmacogenetics In Clinical Care
Condition: Cardiovascular Disease
Intervention: Genetic: SLCO1B1 Genotype
35 Unknown  Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
36 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
37 Completed
Has Results
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
Condition: Blood Clotting
Interventions: Genetic: warfarin pharmacogenetic dosing;   Drug: Warfarin
38 Not yet recruiting A Research in Pharmacogenomics and Accurate Medication of Novel Oral Anticoagulants
Conditions: Novel Oral Anticoagulants;   NOACs;   Rivaroxaban;   Apixaban;   Dabigatran;   Pharmacokinetics;   Pharmacodynamics;   Pharmacogenomics;   Accurate Medication
Intervention: Genetic: detection of genotype
39 Completed Pharmacogenetic Dosage Algorithm for Acenocoumarol
Conditions: Atrial Fibrillation;   Venous Thromboses;   Cardiac Valve Disease
Intervention: Genetic: Acenocoumarol
40 Unknown  Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Condition: Kidney Transplantation
Interventions: Drug: Tacrolimus + Ketoconazole;   Drug: Tacrolimus alone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.